<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9716600" created="13/10/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9716600</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="retinoic_acid" sem="Organic_compound_other">Retinoic acid</term> inhibits <term id="T3" lex="interleukin-4-mediated_IgE_production" sem="Other"><term id="T2" lex="CD40" sem="Protein_molecule">CD40</term> + <term id="T4" lex="interleukin-4" sem="Protein_molecule">interleukin-4</term>-mediated <term id="T5" lex="IgE_production" sem="Other"><term id="T6" lex="IgE" sem="Protein_family_or_group">IgE</term> production</term></term> in vitro.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Retinoic acid inhibits CD40 + interleukin-4-mediated IgE <clueType>production</clueType> in vitro.</clue>
<comment>NER T3 MOD</comment></event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T2"/>
<cause idref="T4"/>
<clue>Retinoic acid inhibits CD40 + interleukin-4-<clueType>mediated</clueType> IgE production in vitro.</clue>
</event>
<event id="E3">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="T1"/>
<clue>Retinoic acid <clueType>inhibits</clueType> CD40 + interleukin-4-mediated IgE production in vitro.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">To elucidate the role of <term id="A1" sem="Organic_compound_other">retinoic acid</term> (<term id="A2" sem="Organic_compound_other">RA</term>) in <term id="T9" lex="interleukin-4_(IL-4)-mediated_B-cell_activation" sem="Other"><term id="T7" lex="anti-CD40" sem="Protein_molecule">anti-<term id="T8" lex="CD40" sem="Protein_molecule">CD40</term></term> + <term id="T10" lex="interleukin-4" sem="Protein_molecule">interleukin-4</term> (<term id="T11" lex="IL-4" sem="Protein_molecule">IL-4</term>)-mediated <term id="A3" sem="Cell_natural">B-cell</term> activation</term>, the effect of 10(-12) to 10(-6) mol/L <term id="T12" lex="RA" sem="Organic_compound_other">RA</term> was studied in <term id="T14" lex="IL-4_(5_ng/mL)-mediated_proliferation" sem="Other"><term id="T13" lex="anti-CD40" sem="Protein_molecule">anti-CD40</term> (1 microgram/mL) + <term id="T15" lex="IL-4" sem="Protein_molecule">IL-4</term> (5 ng/mL)-mediated proliferation</term> and <term id="T16" lex="Ig_synthesis" sem="Other"><term id="A4" sem="Protein_family_or_group">Ig</term> synthesis</term> by <term id="T17" lex="human_peripheral_blood_mononuclear_cell" sem="Cell_natural">human peripheral blood mononuclear cells</term> (<term id="T18" lex="PBMC" sem="Cell_natural">PBMC</term>) and <term id="T19" lex="B_cell" sem="Cell_natural">B cells</term> in <term id="T20" lex="healthy_donor" sem="Multicellular_organism_natural">healthy donors</term>.</sentence>
<event KT="Other" id="E4">
<type class="Physiological_process"/>
<theme idref="A3"/>
<cause idref="T7"/>
<cause idref="T11"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-<linkCause>mediated</linkCause> B-cell <clueType>activation</clueType>, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-mediated proliferation and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells in healthy donors.</clue>
<comment>NER T9,T14 MOD</comment></event>
<event KT="Investigation" id="E5" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E4"/>
<cause idref="A2"/>
<clue><clueKT>To elucidate</clueKT> the <clueType>role</clueType> <linkCause>of</linkCause> retinoic acid (RA) <linkTheme>in</linkTheme> anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-mediated proliferation and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells in healthy donors.</clue>
</event>
<event KT="Other" id="E6">
<type class="Cellular_physiological_process"/>
<theme idref="T18"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-mediated <clueType>proliferation</clueType> and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells <clueLoc>in healthy donors</clueLoc>.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Other" id="E7">
<type class="Cellular_physiological_process"/>
<theme idref="T19"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-mediated <clueType>proliferation</clueType> and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells <clueLoc>in healthy donors</clueLoc>.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Other" id="E8">
<type class="Gene_expression"/>
<theme idref="A4"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-mediated proliferation and Ig <clueType>synthesis</clueType> <clueLoc>by human peripheral blood mononuclear cells (PBMC)</clueLoc> and B cells <clueLoc>in healthy donors</clueLoc>.</clue>
</event>
<event KT="Other" id="E108">
<type class="Gene_expression"/>
<theme idref="A4"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-mediated proliferation and Ig <clueType>synthesis</clueType> <clueLoc>by human</clueLoc> peripheral blood mononuclear cells (PBMC) and <clueLoc>B cells in healthy donors</clueLoc>.</clue>
</event>
<event KT="Other" id="E9" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T13"/>
<cause idref="T15"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-<clueType>mediated</clueType> proliferation and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells in healthy donors.</clue>
</event>
<event KT="Other" id="E10" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T13"/>
<cause idref="T15"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-<clueType>mediated</clueType> proliferation and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells in healthy donors.</clue>
</event>
<event KT="Other" id="E11" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T13"/>
<cause idref="T15"/>
<clue>To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10(-12) to 10(-6) mol/L RA was studied in anti-CD40 (1 microgram/mL) + IL-4 (5 ng/mL)-<clueType>mediated</clueType> proliferation and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells in healthy donors.</clue>
</event>
<sentence id="S3"><term id="T21" lex="anti-CD40_+_IL-4-mediated_proliferation" sem="Other"><term id="T22" lex="anti-CD40" sem="Protein_molecule">Anti-CD40</term> + <term id="T23" lex="IL-4" sem="Protein_molecule">IL-4</term>-mediated proliferation</term> of <term id="T24" lex="PBMC" sem="Cell_natural">PBMC</term> and <term id="T25" lex="B_cell" sem="Cell_natural">B cells</term> was inhibited by <term id="T26" lex="RA" sem="Organic_compound_other">RA</term> in a <term id="T27" lex="dose-dependent_manner" sem="Other">dose-dependent manner</term>, with <term id="T28" lex="maximal_inhibition" sem="Other">maximal inhibition</term> of 62% +/- 5% in <term id="T29" lex="PBMC" sem="Cell_natural">PBMC</term> and 55% +/- 4.4% in <term id="T30" lex="B_cell" sem="Cell_natural">B cells</term> by <term id="T31" lex="RA" sem="Organic_compound_other">all-trans RA</term>, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by <term id="T32" lex="13-cis_RA" sem="Organic_compound_other">13-cis RA</term>.</sentence>
<event KT="Other" id="E12">
<type class="Cellular_physiological_process"/>
<theme idref="T24"/>
<clue>Anti-CD40 + IL-4-mediated <clueType>proliferation</clueType> <linkTheme>of</linkTheme> PBMC and B cells was inhibited by RA in a dose-dependent manner, with maximal inhibition of 62% +/- 5% in PBMC and 55% +/- 4.4% in B cells by all-trans RA, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by 13-cis RA.</clue>
</event>
<event KT="Other" id="E13">
<type class="Cellular_physiological_process"/>
<theme idref="T25"/>
<clue>Anti-CD40 + IL-4-mediated <clueType>proliferation</clueType> <linkTheme>of</linkTheme> PBMC and B cells was inhibited by RA in a dose-dependent manner, with maximal inhibition of 62% +/- 5% in PBMC and 55% +/- 4.4% in B cells by all-trans RA, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by 13-cis RA.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T22"/>
<cause idref="T23"/>
<clue>Anti-CD40 + IL-4-<clueType>mediated</clueType> proliferation of PBMC and B cells was inhibited by RA in a dose-dependent manner, with maximal inhibition of 62% +/- 5% in PBMC and 55% +/- 4.4% in B cells by all-trans RA, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by 13-cis RA.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T22"/>
<cause idref="T23"/>
<clue>Anti-CD40 + IL-4-<clueType>mediated</clueType> proliferation of PBMC and B cells was inhibited by RA in a dose-dependent manner, with maximal inhibition of 62% +/- 5% in PBMC and 55% +/- 4.4% in B cells by all-trans RA, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by 13-cis RA.</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T26"/>
<clue>Anti-CD40 + IL-4-mediated proliferation of PBMC and B cells was <clueType>inhibited</clueType> <linkCause>by</linkCause> RA in a dose-dependent manner, with maximal inhibition of 62% +/- 5% in PBMC and 55% +/- 4.4% in B cells by all-trans RA, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by 13-cis RA.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T26"/>
<clue>Anti-CD40 + IL-4-mediated proliferation of PBMC and B cells was <clueType>inhibited</clueType> <linkCause>by</linkCause> RA in a dose-dependent manner, with maximal inhibition of 62% +/- 5% in PBMC and 55% +/- 4.4% in B cells by all-trans RA, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by 13-cis RA.</clue>
</event>
<event Manner="High" id="E101">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T31"/>
<clue>Anti-CD40 + IL-4-mediated proliferation of PBMC and B cells was inhibited by RA in a dose-dependent manner, with <clueManner>maximal</clueManner> <clueType>inhibition</clueType> <clueManner>of 62%</clueManner> +/- 5% <clueLoc>in PBMC</clueLoc> <clueManner>and 55%</clueManner> +/- 4.4% <clueLoc>in B cells</clueLoc> <linkCause>by</linkCause> all-trans RA, and 58% +/- 6.7% and 51% +/- 4.7%, respectively by 13-cis RA.</clue>
<comment>NER T31 MOD, NO COREFTHEME</comment></event>
<event Manner="High" id="E102">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T32"/>
<clue>Anti-CD40 + IL-4-mediated proliferation of PBMC and B cells was inhibited by RA in a dose-dependent manner, with <clueManner>maximal</clueManner> <clueType>inhibition</clueType> of 62% +/- 5% <clueLoc>in PBMC</clueLoc> and 55% +/- 4.4% <clueLoc>in B cells</clueLoc> by all-trans RA, and <clueManner>58%</clueManner> +/- 6.7% <clueManner>and 51%</clueManner> +/- 4.7%, respectively <linkCause>by</linkCause> 13-cis RA.</clue>
<comment>NO COREFTHEME</comment></event>
<sentence id="S4"><term id="T33" lex="IgE" sem="Protein_family_or_group">IgE</term> synthesis was even more markedly inhibited by <term id="T34" lex="RA" sem="Organic_compound_other">RA</term> starting at concentrations of &gt;10(-14) mol/L for <term id="T35" lex="B_cell" sem="Cell_natural">B cells</term> and &gt;10(-10) mol/L for <term id="T36" lex="PBMC" sem="Cell_natural">PBMC</term>.</sentence>
<event KT="Other" id="E18">
<type class="Gene_expression"/>
<theme idref="T33"/>
<clue>IgE <clueType>synthesis</clueType> was even more markedly inhibited by RA starting at concentrations of &gt;10(-14) mol/L for B cells and &gt;10(-10) mol/L for PBMC.</clue>
</event>
<event Manner="High" id="E19">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="T34"/>
<clue>IgE synthesis was <clueManner>even more markedly</clueManner> <clueType>inhibited</clueType> <linkCause>by</linkCause> RA starting at concentrations of &gt;10(-14) mol/L for <clueLoc>B cells</clueLoc> and &gt;10(-10) mol/L for <clueLoc>PBMC</clueLoc>.</clue>
</event>
<sentence id="S5"><term id="T37" lex="maximal_inhibition" sem="Other">Maximal inhibition</term> of <term id="T38" lex="IgE_production" sem="Other"><term id="T39" lex="IgE" sem="Protein_family_or_group">IgE</term> production</term> for <term id="T40" lex="B_cell" sem="Cell_natural">B cells</term> was at 10(-8) mol/L for <term id="T41" lex="RA" sem="Organic_compound_other">all-trans RA</term> (94% +/- 1.8%) and 96% +/- 3.2% for <term id="T42" lex="RA" sem="Organic_compound_other">13-cis RA</term>.</sentence>
<event KT="Other" id="E20">
<type class="Gene_expression"/>
<theme idref="T39"/>
<clue>Maximal inhibition of IgE <clueType>production</clueType> for B cells was at 10(-8) mol/L for all-trans RA (94% +/- 1.8%) and 96% +/- 3.2% for 13-cis RA.</clue>
<comment>NER T41,T42 MOD</comment></event>
<event Manner="High" id="E21">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T41"/>
<clue><clueManner>Maximal</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IgE production for <clueLoc>B cells</clueLoc> was at 10(-8) mol/L <linkCause>for</linkCause> all-trans RA (<clueManner>94%</clueManner> +/- 1.8%) and 96% +/- 3.2% for 13-cis RA.</clue>
</event>
<event Manner="High" id="E22">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T42"/>
<clue><clueManner>Maximal</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IgE production for <clueLoc>B cells</clueLoc> was at 10(-8) mol/L for all-trans RA (94% +/- 1.8%) <clueManner>and 96%</clueManner> +/- 3.2% <linkCause>for</linkCause> 13-cis RA.</clue>
</event>
<sentence id="S6">Low concentrations of <term id="T43" lex="RA" sem="Organic_compound_other">RA</term> inhibiting <term id="T44" lex="IgE_synthesis" sem="Other"><term id="T45" lex="IgE" sem="Protein_family_or_group">IgE</term> synthesis</term> (10(-10) mol/L) affected neither <term id="T46" lex="B-cell_proliferation" sem="Other"><term id="A5" sem="Cell_natural">B-cell</term> proliferation</term> nor the production of <term id="T47" lex="IgA" sem="Protein_molecule">IgA</term>, <term id="T48" lex="IgG" sem="Protein_molecule">IgG</term>, and <term id="T49" lex="IgM" sem="Protein_molecule">IgM</term>.</sentence>
<event Manner="Low" id="E23">
<type class="Gene_expression"/>
<theme idref="T45"/>
<clue><clueManner>Low concentrations of</clueManner> RA inhibiting IgE <clueType>synthesis</clueType> (10(-10) mol/L) affected neither B-cell proliferation nor the production of IgA, IgG, and IgM.</clue>
</event>
<event id="E24">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T43"/>
<clue>Low concentrations of RA <clueType>inhibiting</clueType> IgE synthesis (10(-10) mol/L) affected neither B-cell proliferation nor the production of IgA, IgG, and IgM.</clue>
</event>
<event id="E25">
<type class="Cellular_physiological_process"/>
<theme idref="A5"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) affected neither B-cell <clueType>proliferation</clueType> nor the production of IgA, IgG, and IgM.</clue>
</event>
<event id="E26">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) affected neither B-cell proliferation nor the <clueType>production</clueType> <linkTheme>of</linkTheme> IgA, IgG, and IgM.</clue>
</event>
<event id="E27">
<type class="Gene_expression"/>
<theme idref="T48"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) affected neither B-cell proliferation nor the <clueType>production</clueType> <linkTheme>of</linkTheme> IgA, IgG, and IgM.</clue>
</event>
<event id="E28">
<type class="Gene_expression"/>
<theme idref="T49"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) affected neither B-cell proliferation nor the <clueType>production</clueType> <linkTheme>of</linkTheme> IgA, IgG, and IgM.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E29">
<type class="Regulation"/>
<theme idref="E25"/>
<cause idref="T43"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) <clueType>affected</clueType> <cluePolarity>neither</cluePolarity> B-cell proliferation nor the production of IgA, IgG, and IgM.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E30">
<type class="Regulation"/>
<theme idref="E26"/>
<cause idref="T43"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) <clueType>affected</clueType> neither B-cell proliferation <cluePolarity>nor</cluePolarity> the production of IgA, IgG, and IgM.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E31">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T43"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) <clueType>affected</clueType> neither B-cell proliferation <cluePolarity>nor</cluePolarity> the production of IgA, IgG, and IgM.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Regulation"/>
<theme idref="E28"/>
<cause idref="T43"/>
<clue>Low concentrations of RA inhibiting IgE synthesis (10(-10) mol/L) <clueType>affected</clueType> neither B-cell proliferation <cluePolarity>nor</cluePolarity> the production of IgA, IgG, and IgM.</clue>
</event>
<sentence id="S7">Elucidation of the mechanism involved in this inhibition of <term id="T50" lex="IgE_production" sem="Other"><term id="T51" lex="IgE" sem="Protein_family_or_group">IgE</term> production</term> shows that <term id="T52" lex="epsilon_germline_transcription" sem="Other"><term id="T53" lex="germline_promotor" sem="DNA_domain_or_region">epsilon germline</term> transcription</term> is decreased by <term id="T54" lex="RA" sem="Organic_compound_other">RA</term>, whereas production of <term id="T55" lex="interferon-gamma" sem="Protein_molecule">interferon-gamma</term> (<term id="T56" lex="IFN-gamma" sem="Protein_molecule">IFN-gamma</term>) was not enhanced in the presence of <term id="T57" lex="RA" sem="Organic_compound_other">RA</term>.</sentence>
<event KT="Other" id="E33">
<type class="Gene_expression"/>
<theme idref="T51"/>
<clue>Elucidation of the mechanism involved in this inhibition of IgE <clueType>production</clueType> shows that epsilon germline transcription is decreased by RA, whereas production of interferon-gamma (IFN-gamma) was not enhanced in the presence of RA.</clue>
<comment>NER T53 MOD</comment></event>
<event KT="Investigation" id="E34">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T43"/>
<clue><clueKT>Elucidation</clueKT> of the mechanism involved in <corefCause>this</corefCause> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IgE production shows that epsilon germline transcription is decreased by RA, whereas production of interferon-gamma (IFN-gamma) was not enhanced in the presence of RA.</clue>
</event>
<event KT="Other" id="E35">
<type class="Transcription"/>
<theme idref="T53"/>
<clue>Elucidation of the mechanism involved in this inhibition of IgE production shows that epsilon germline <clueType>transcription</clueType> is decreased by RA, whereas production of interferon-gamma (IFN-gamma) was not enhanced in the presence of RA.</clue>
</event>
<event KT="Analysis" id="E36">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="T54"/>
<clue>Elucidation of the mechanism involved in this inhibition of IgE production <clueKT>shows</clueKT> that epsilon germline transcription is <clueType>decreased</clueType> <linkCause>by</linkCause> RA, whereas production of interferon-gamma (IFN-gamma) was not enhanced in the presence of RA.</clue>
</event>
<event KT="Other" id="E37">
<type class="Gene_expression"/>
<theme idref="T56"/>
<clue>Elucidation of the mechanism involved in this inhibition of IgE production shows that epsilon germline transcription is decreased by RA, whereas <clueType>production</clueType> <linkTheme>of</linkTheme> interferon-gamma (IFN-gamma) was not enhanced in the presence of RA.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E38">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T57"/>
<clue>Elucidation of the mechanism involved in this inhibition of IgE production <clueKT>shows</clueKT> that epsilon germline transcription is decreased by RA, whereas production of interferon-gamma (IFN-gamma) was <cluePolarity>not</cluePolarity> <clueType>enhanced</clueType> <linkCause>in the presence of</linkCause> RA.</clue>
</event>
<sentence id="S8">To differentiate whether the <term id="T58" lex="RA" sem="Organic_compound_other">RA</term> effect was mediated by <cons id="T59" lex="(AND RA_receptor_alpha RA_receptor_beta RA_receptor_gamma)" sem="(AND Protein_molecule Protein_molecule Protein_molecule)"><frag id="F1"><term id="A6" sem="Protein_molecule">RA receptors</term></frag> <frag id="F2"><term id="A7" sem="Protein_molecule">alpha</term></frag>, <frag id="F3"><term id="A8" sem="Protein_molecule">beta</term></frag>, and <frag id="F4"><term id="A9" sem="Protein_molecule">gamma</term></frag></cons>, the expression of the <term id="T60" lex="retinoic_acid_receptor" sem="Protein_family_or_group">retinoic acid receptors</term> (<term id="T61" lex="RAR" sem="Protein_family_or_group">RAR</term>) was examined by <term id="T62" lex="reverse_transcriptase-polymerase_chain_reaction" sem="Other"><term id="T63" lex="reverse_transcriptase" sem="Protein_molecule">reverse transcriptase</term>-polymerase chain reaction</term> (<term id="T64" lex="RT-PCR" sem="Other">RT-PCR</term>).</sentence>
<event KT="Other" id="E39">
<type class="Regulation"/>
<cause idref="T58"/>
<clue>To differentiate whether the RA <clueType>effect</clueType> was mediated by RA receptors alpha, beta, and gamma, the expression of the retinoic acid receptors (RAR) was examined by reverse transcriptase-polymerase chain reaction (RT-PCR).</clue>
</event>
<event KT="Investigation" id="E40" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="A6" idref1="A7"/>
<clue><clueKT>To differentiate</clueKT> whether the RA effect was <clueType>mediated</clueType> <linkCause>by</linkCause> RA receptors alpha, beta, and gamma, the expression of the retinoic acid receptors (RAR) was examined by reverse transcriptase-polymerase chain reaction (RT-PCR).</clue>
</event>
<event KT="Investigation" id="E41" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="A6" idref1="A8"/>
<clue><clueKT>To differentiate</clueKT> whether the RA effect was <clueType>mediated</clueType> <linkCause>by</linkCause> RA receptors alpha, beta, and gamma, the expression of the retinoic acid receptors (RAR) was examined by reverse transcriptase-polymerase chain reaction (RT-PCR).</clue>
</event>
<event KT="Investigation" id="E42" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="A6" idref1="A9"/>
<clue><clueKT>To differentiate</clueKT> whether the RA effect was <clueType>mediated</clueType> <linkCause>by</linkCause> RA receptors alpha, beta, and gamma, the expression of the retinoic acid receptors (RAR) was examined by reverse transcriptase-polymerase chain reaction (RT-PCR).</clue>
</event>
<event KT="Investigation" id="E43" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T61"/>
<clue>To differentiate whether the RA effect was mediated by RA receptors alpha, beta, and gamma, the <clueType>expression</clueType> <linkTheme>of</linkTheme> the retinoic acid receptors (RAR) was <clueKT>examined</clueKT> by <clueExperiment>reverse transcriptase-polymerase chain reaction (RT-PCR)</clueExperiment>.</clue>
</event>
<sentence id="S9">The data show that <term id="T65" lex="unstimulated_human_peripheral_B_cell" sem="Cell_natural">unstimulated <term id="A25" sem="Cell_natural">human peripheral B cells</term></term> express <term id="A24" sem="RNA_molecule">mRNA of</term> the <cons id="T66" lex="(AND RA_receptor_alpha RA_receptor_beta RA_receptor_gamma)" sem="(AND Protein_molecule Protein_molecule Protein_molecule)"><frag id="F5"><term id="A20" sem="RNA_molecule">RA receptor</term></frag> <frag id="F6"><term id="A21" sem="RNA_molecule">alpha</term></frag>, <frag id="F7"><term id="A22" sem="RNA_molecule">beta</term></frag>, and <frag id="F8"><term id="A23" sem="RNA_molecule">gamma</term></frag></cons>.</sentence>
<event KT="Analysis" id="E44">
<type class="Transcription"/>
<theme idref="A24" idref1="A20" idref2="A21"/>
<clue>The data <clueKT>show</clueKT> that <clueLoc>unstimulated human peripheral B cells</clueLoc> <clueType>express</clueType> mRNA of the RA receptor alpha, beta, and gamma.</clue>
</event>
<event KT="Analysis" id="E45">
<type class="Transcription"/>
<theme idref="A24" idref1="A20" idref2="A22"/>
<clue>The data <clueKT>show</clueKT> that <clueLoc>unstimulated human peripheral B cells</clueLoc> <clueType>express</clueType> mRNA of the RA receptor alpha, beta, and gamma.</clue>
</event>
<event KT="Analysis" id="E46">
<type class="Transcription"/>
<theme idref="A24" idref1="A20" idref2="A23"/>
<clue>The data <clueKT>show</clueKT> that <clueLoc>unstimulated human peripheral B cells</clueLoc> <clueType>express</clueType> mRNA of the RA receptor alpha, beta, and gamma.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E47">
<type class="Physiological_process"/>
<theme idref="A25"/>
<clue>The data show that <clueType><cluePolarity>unstimulated</cluePolarity></clueType> human peripheral B cells express mRNA of the RA receptor alpha, beta, and gamma.</clue>
</event>
<sentence id="S10">Using <term id="T67" lex="retinoid" sem="Organic_compound_other">retinoids</term> with different <term id="A26" sem="Protein_family_or_group">receptor</term> binding specificity (<term id="T68" lex="CD336" sem="Organic_compound_other">CD336</term>, <term id="T69" lex="CD437" sem="Organic_compound_other">CD437</term>, <term id="T70" lex="CD2019" sem="Organic_compound_other">CD2019</term>, <term id="T71" lex="CD367" sem="Organic_compound_other">CD367</term>), dose-dependent inhibition of <term id="T72" lex="IgE" sem="Protein_family_or_group">IgE</term> synthesis was shown by all four derivates, but was most marked by an <term id="T73" lex="RA" sem="Organic_compound_other">RA</term> binding the <term id="T74" lex="alpha_receptor" sem="Protein_molecule">alpha receptor</term> with high specificity.</sentence>
<event id="E48">
<type class="Binding"/>
<theme idref="T67"/>
<theme idref="A26"/>
<clue>Using retinoids <linkTheme>with</linkTheme> different receptor <clueType>binding specificity</clueType> (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE synthesis was shown by all four derivates, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event id="E49">
<type class="Binding"/>
<theme idref="T68"/>
<theme idref="A26"/>
<clue>Using <corefTheme>retinoids</corefTheme> <linkTheme>with</linkTheme> different receptor <clueType>binding specificity</clueType> (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE synthesis was shown by all four derivates, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event id="E50">
<type class="Binding"/>
<theme idref="T69"/>
<theme idref="A26"/>
<clue>Using <corefTheme>retinoids</corefTheme> <linkTheme>with</linkTheme> different receptor <clueType>binding specificity</clueType> (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE synthesis was shown by all four derivates, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event id="E51">
<type class="Binding"/>
<theme idref="T70"/>
<theme idref="A26"/>
<clue>Using <corefTheme>retinoids</corefTheme> <linkTheme>with</linkTheme> different receptor <clueType>binding specificity</clueType> (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE synthesis was shown by all four derivates, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event id="E151">
<type class="Binding"/>
<theme idref="T71"/>
<theme idref="A26"/>
<clue>Using <corefTheme>retinoids</corefTheme> <linkTheme>with</linkTheme> different receptor <clueType>binding specificity</clueType> (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE synthesis was shown by all four derivates, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event KT="Other" id="E52">
<type class="Gene_expression"/>
<theme idref="T72"/>
<clue>Using retinoids with different receptor binding specificity (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE <clueType>synthesis</clueType> was shown by all four derivates, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event KT="Analysis" id="E53">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="T68"/>
<clue>Using retinoids with different receptor binding specificity (CD336, CD437, CD2019, CD367), dose-dependent <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IgE synthesis was <clueKT>shown</clueKT> <linkCause>by</linkCause> <corefCause>all four derivates</corefCause>, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event KT="Analysis" id="E54">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="T69"/>
<clue>Using retinoids with different receptor binding specificity (CD336, CD437, CD2019, CD367), dose-dependent <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IgE synthesis was <clueKT>shown</clueKT> <linkCause>by</linkCause> <corefCause>all four derivates</corefCause>, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event KT="Analysis" id="E55">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="T70"/>
<clue>Using retinoids with different receptor binding specificity (CD336, CD437, CD2019, CD367), dose-dependent <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IgE synthesis was <clueKT>shown</clueKT> <linkCause>by</linkCause> <corefCause>all four derivates</corefCause>, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event KT="Analysis" id="E56">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="T71"/>
<clue>Using retinoids with different receptor binding specificity (CD336, CD437, CD2019, CD367), dose-dependent <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IgE synthesis was <clueKT>shown</clueKT> <linkCause>by</linkCause> <corefCause>all four derivates</corefCause>, but was most marked by an RA binding the alpha receptor with high specificity.</clue>
</event>
<event Manner="High" id="E57">
<type class="Binding"/>
<theme idref="T73"/>
<theme idref="T74"/>
<clue>Using retinoids with different receptor binding specificity (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE synthesis was shown by all four derivates, but was <clueManner>most marked</clueManner> by an RA <clueType>binding</clueType> the alpha receptor with high specificity.</clue>
</event>
<sentence id="S11">Taken together, this study shows that <term id="T75" lex="RA" sem="Organic_compound_other">RA</term> inhibits <term id="T76" lex="IgE_production" sem="Other"><term id="T77" lex="IgE" sem="Protein_family_or_group">IgE</term> production</term> of <term id="T78" lex="anti-CD40_+_IL-4-stimulated_B_cell" sem="Cell_cultured"><term id="T79" lex="anti-CD40" sem="Protein_molecule">anti-CD40</term> + <term id="T80" lex="IL-4" sem="Protein_molecule">IL-4</term>-stimulated <term id="A27" sem="Cell_natural">B cells</term></term> in vitro.</sentence>
<event KT="Other" id="E58">
<type class="Gene_expression"/>
<theme idref="T77"/>
<clue>Taken together, this study shows that RA inhibits IgE <clueType>production</clueType> <clueLoc>of anti-CD40 + IL-4-stimulated B cells</clueLoc> in vitro.</clue>
</event>
<event KT="Analysis" id="E59">
<type class="Negative_regulation"/>
<theme idref="E58"/>
<cause idref="T75"/>
<clue>Taken together, this study <clueKT>shows</clueKT> that RA <clueType>inhibits</clueType> IgE production of anti-CD40 + IL-4-stimulated B cells in vitro.</clue>
</event>
<event KT="Other" id="E60">
<type class="Physiological_process"/>
<theme idref="A27"/>
<cause idref="T79"/>
<cause idref="T80"/>
<clue>Taken together, this study shows that RA inhibits IgE production of anti-CD40 + IL-4-<clueType>stimulated</clueType> B cells in vitro.</clue>
</event>
<sentence id="S12">Copyright 1998 by The American Society of Hematology.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
